News
AI In Health And Beyond: What To Expect In 2025
Artificial Intelligence is progressing quickly. From chatbots to generative AI content, the technology is being used in virtually every industry. And, as it enjoys more widespread use, it is becoming more advanced.
AI content is becoming more difficult to detect, and its use in data analysis is producing results across businesses and industries. In healthcare, as in most industries, AI is being used for everything from communication to automated data analysis and, in 2025, the industry will see greater innovation and improvements.
AI Improvements
The idea of artificial intelligence dates back to the automatons of ancient Greece, although the start of modern AI can be dated to the 1950s, especially Alan Turing’s imitation game (now known as the Turing Test). The technology has become prevalent in the past few years, though, as technology like smartphones and advanced processors have expanded artificial intelligence.
Today, the best AI apps for iPhone can generate AI voices and art. They can also, according to senior technology writer Alice Martin, be used to manage social media. As well as its benefits for personal use, AI is also a powerful tool used in the healthcare industry.
Improved Chatbot Communication
Chatbots can be used to answer quick questions and direct users to appropriate answers. Within the healthcare industry, these tools can be used to answer patient calls and direct the caller to the most appropriate ward or department.
As AI continues to develop, being trained by healthcare and communication specialists, it will be better equipped to deal with more complex enquiries. Although it is still some way off, AI could eventually be used to assist with diagnosis.
Administrative Assistance
As well as being used as chatbots for rapid responses to queries, AI can be deployed as virtual assistants. Virtual assistants are more advanced than chatbots and can manage calendars, arrange and rearrange meetings, and perform other tasks for healthcare professionals. They can also be used to book appointments, send follow-up letters, and offer more advanced features to patients.
Dealing With Data
AI is well-equipped to handle, read, and manipulate large volumes of data. This makes it especially useful for administrative tasks. As well as being able to work with patient data and health records, AI can aid in everything from patient applications to marketing and advertising. Patient data records must be accurate, and different departments and different organizations may hold different data on patients. This data needs to be amalgamated to provide the greatest benefits and assist in accurate diagnoses.
Marketing Prediction
Marketing is another area that relies on the use of large sets of data. It also uses predictive modelling and optimization, and these are areas where artificial intelligence is already well advanced. These marketing features can be used by healthcare institutions and private healthcare facilities, as well as pharmaceutical companies and manufacturers.
The health insurance industry will also benefit from more reliable and targeted marketing campaigns backed by predictive modelling.
Fraud Detection
Fraud is fairly commonplace within the healthcare industry and it is estimated that it costs the industry $250 billion a year or more. Typical fraud cases involve individuals fraudulently making claims against insurance, but they can also involve healthcare facilities and providers altering claims or submitting larger claims than are reasonable. Insurance companies invest large sums to try and identify and combat this type of fraud, and AI is positioned to help.
Machine learning algorithms are used to analyze the behaviors of individuals and healthcare providers. These algorithms can detect any anomalous activity, which may be indicative of fraudulent activity. AI can compare claims to previous claims by the same patient, as well as patterns established across the industry. With more data comes more accurate results, and 2025 is likely to see AI implemented in this way with greater frequency.
Improved AI Diagnostics
The healthcare industry has a wealth of diagnostic tools, with more tests regularly being introduced. Test results can include data provided by the patients themselves to medical imaging, blood tests, and more. Any one of these diagnostic tools can identify potential conditions.
When healthcare providers are looking at diagnostic information, they tend to look for very specific indicators, whereas AI can be used to highlight other, otherwise unseen, symptoms and signs. Various AI companies and specialists are looking at ways to improve AI diagnostics, and even Google is known to be advancing in this area of AI research.
Personalized Medication Plans
Medication plans are used in the treatment of various conditions and can require complex combinations of different types of treatment as well as various medications. AI can analyze patient responses to medication, as well as study treatment outcomes from other patients.
Using this information, AI can potentially develop more accurate and more effective medication plans, and so in real-time, while checking patient records for any potential issues. This also frees up time for healthcare providers to be able to meet with patients and receive diagnostic answers.
Predictive Analytics
Predictive analytics can be used throughout the patient journey, as well as in administrative roles within the healthcare industry. It can be used to predict potential outbreaks of illnesses or to predict the course of an individual’s illness. It can also be used to predict health and wellness epidemics that will sweep through nations, and then to use this and other information to devise action plans to help prevent the spread.
2025 is likely to see further moves into multimodal AI within healthcare. Multimodal AI means taking and using data from multiple sources. This will not only include diagnostic test results, but patient details from other sources.
Medical Claim And Insurance Assessments
Health insurance and medical claims are important components of the healthcare industry. Insurance underwriters use predictive modelling, taking into account patient data and previous health tests, to help determine the risks they pose.
To do this, they need to analyze large data sets related to applicants and the population as a whole. Machine learning algorithms use data that is updated in real-time to assess risks on the fly. AI can also be used to process medical claims and to identify likely fraud.
AI Regulations
AI is an emerging field. Some of the biggest companies in the world are working on their own AI solutions, and it is being implemented in various big industries, including healthcare. While this does mean that the technology continues to advance, it also means that patients and individuals need safeguarding.
As such, governments and government agencies are working on ways to implement safeguarding procedures and policies. 2025 is likely to see further AI regulation, and this will continue, especially as the technology becomes more advanced and as it is used to deal with highly personal information like medical records.
Conclusion
AI is a disruptive technology, and while it certainly isn’t a new technology, it has seen considerable jumps forward in the past few years. As well as being used in the development of different forms of content, it has found use in marketing, communication, and across a host of different industries and markets. Healthcare’s use of big data and its need for up-to-date analysis means that artificial intelligence continues to gain prominence within healthcare companies.
Diagnosis
Lung cancer drug shows breast cancer potential
Ovarian cancer cells quickly activate survival responses after PARP inhibitor treatment, and a lung cancer drug could help block this, research suggests.
PARP inhibitors are a common treatment for ovarian cancer, particularly in tumours with faulty DNA repair. They stop cancer cells fixing DNA damage, which leads to cell death, but many tumours later stop responding.
Researchers identified a way cancer cells may survive PARP inhibitor treatment from the outset, pointing to a potential way to block that response. A Mayo Clinic team found ovarian cancer cells rapidly switch on a pro-survival programme after exposure to PARP inhibitors. A key driver is FRA1, a transcription factor (a protein that turns genes on and off) that helps cancer cells adapt and avoid death.
The team then tested whether brigatinib, a drug approved for certain lung cancers, could block this response and boost the effect of PARP inhibitors. Brigatinib was chosen because it inhibits multiple signalling pathways involved in cancer cell survival.
In laboratory studies, combining brigatinib with a PARP inhibitor was more effective than either treatment alone. Notably, the effect was seen in cancer cells but not normal cells, suggesting a more targeted approach.
Brigatinib also appeared to act in an unexpected way. Rather than working through the usual DNA repair routes, it shut down two signalling molecules, FAK and EPHA2, that aggressive ovarian cancer cells rely on. FAK and EPHA2 are proteins that relay survival signals inside cells. Blocking both at once weakened the cells’ ability to adapt and resist treatment, making them more vulnerable to PARP inhibitors.
Tumours with higher levels of FAK and EPHA2 responded better to the drug combination. Other data link high levels of these molecules to more aggressive disease, pointing to potential benefit in harder-to-treat cases.
Arun Kanakkanthara, an oncology investigator at Mayo Clinic and a senior author of the study, said: “This work shows that drug resistance does not always emerge slowly over time; cancer cells can activate survival programmes very early after treatment begins.”
John Weroha, a medical oncologist at Mayo Clinic and a senior author of the study, said: “From a clinical perspective, resistance remains one of the biggest challenges in treating ovarian cancer. By combining mechanistic insights from Dr Kanakkanthara’s laboratory with my clinical experience, this preclinical work supports the strategy of targeting resistance early, before it has a chance to take hold. This strategy could improve patient outcomes.”
Insight
Higher nighttime temps linked to increased risk of autism diagnosis in children – study
Entrepreneur
Kindbody unveils next-gen fertility platform
-
Insight4 weeks agoDesigner perfumes recalled over banned chemical posing fertility risk
-
Insight2 weeks agoParents sue IVF clinic after delivering someone else’s baby
-
Insight3 weeks agoWomen’s health could unlock US$100bn by 2030
-
Insight4 weeks agoChina’s birth rate hits record low despite government fertility efforts
-
Menopause3 weeks agoHRT linked to greater weight loss on tirzepatide
-
Entrepreneur6 days agoUS startup builds wearable hormone tracker
-
Wellness2 weeks agoFlo Health and Mayo Clinic publish global perimenopause awareness study
-
Entrepreneur4 weeks agoVerdane invest in Clue to accelerate the future of women’s health






